Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis

Drugs & Aging
Céline PhanGEM Resopso

Abstract

Apremilast is a drug recently developed for psoriasis. Few data are available on its use in the elderly. We evaluated the tolerance and effectiveness of apremilast used in daily practice for psoriasis treatment in older patients. We performed a multicenter, retrospective study involving patients aged ≥ 65 years who had received apremilast as a psoriasis treatment. Demographic data and details regarding psoriasis and adverse events (AEs) were collected from patient medical records. 135 patients were included (mean age: 73.5 years). Treatment was stopped in 74 patients (54.8%) for AEs (n = 43, 56.6%), primary failures (n = 18, 23.4%), and relapses (n = 7, 9.2%). When patients were stratified by age at treatment initiation, the main cause of discontinuation in patients ≥ 75 years was AEs, whereas in patients aged 65-74 years it was primary failures (28.3%). Sixty-one patients reported AEs, mainly digestive (n = 49). Regarding effectiveness, 45.2% of patients reached PGA 0/1 between 3 and 6 months after treatment initiation. One-year apremilast continuation rates were better in the 65-74 and 75-84 years subgroups than in the > 85 years subgroup (p = 0.01). Apremilast seems to be an effective and safe therapeutic option for psoriasi...Continue Reading

References

Sep 1, 1985·Journal of the American Academy of Dermatology·T Henseler, E Christophers
Jul 13, 2002·Archives of Dermatological Research·Philip StuartJames T Elder
Dec 21, 2011·International Journal of Dermatology·Hyuck Hoon KwonJai Il Youn
Oct 26, 2013·Acta Dermato-venereologica·Stefano PiasericoNicoletta Cassano
Feb 21, 2014·Drugs & Aging·Nicola BalatoRaffaele Scarpa
Nov 13, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·C PhanUNKNOWN GEM RESOPSO
Jul 30, 2017·Drugs & Aging·Joseph G Kamel, Paul S Yamauchi
Nov 25, 2017·Expert Opinion on Pharmacotherapy·Abigail ClineSteven R Feldman
Feb 2, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·E PapadavidD Rigopoulos
Jul 24, 2018·Expert Opinion on Biological Therapy·Vito Di Lernia, Mohamad Goldust
Sep 1, 2018·The Journal of Dermatology·Megumi KishimotoMamitaro Ohtsuki
Jan 18, 2020·Journal of Cutaneous Medicine and Surgery·Vijay Kumari SandhuCharles W Lynde
Apr 12, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·M MegnaE Cinelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Actas dermo-sifiliográficas
A Pérez Ferriols
Journal of Cutaneous Medicine and Surgery
Julia N Mayba, M Gooderham
Actas dermo-sifiliográficas
J M CarrascosaP Herranz
© 2021 Meta ULC. All rights reserved